Cargando…
Real-world use of ustekinumab therapeutic drug monitoring in moderate to severe psoriasis
INTRODUCTION: There is growing evidence that therapeutic drug monitoring of biologic therapy is beneficial in psoriatic patients. With respect to ustekinumab, the available evidence has not shown any relationship yet. The objective of this study is to identify correlations among ustekinumab trough c...
Autores principales: | Elberdín, Laida, Fernández-Torres, Rosa M., Mateos, María, Outeda, María, Blanco, Eva, Gómez-Besteiro, María I., Martín-Herranz, Isabel, Fonseca, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773264/ https://www.ncbi.nlm.nih.gov/pubmed/36569163 http://dx.doi.org/10.3389/fmed.2022.1017323 |
Ejemplares similares
-
Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago
por: Elberdín, Laida, et al.
Publicado: (2022) -
Safety of ustekinumab in adolescent patients with moderate‐to‐severe plaque psoriasis: real‐world evidence from an ongoing European study (NCT03218488)
por: Mahé, E., et al.
Publicado: (2022) -
Budget impact analysis of ustekinumab in the management of moderate to severe psoriasis in Greece
por: Avgerinou, Georgia, et al.
Publicado: (2012) -
Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
por: Chan, Wai Sze Agnes, et al.
Publicado: (2022) -
Ustekinumab: differential use in psoriasis
por: Uhlenhake, Elizabeth E, et al.
Publicado: (2011)